open access

Vol 22, No 1 (2017)
Original research articles
Published online: 2017-01-01
Submitted: 2015-06-27
Get Citation

Dosimetric influence of filtered and flattening filter free photon beam on rapid arc (RA) radiotherapy planning in case of cervix carcinoma

Lalit Kumar, Girigesh Yadav, Kothanda Raman Samuvel, Manindra Bhushan, Pawan Kumar, Mahammood Suhail, Manoj Pal
DOI: 10.1016/j.rpor.2016.09.010
·
Rep Pract Oncol Radiother 2017;22(1):10-18.

open access

Vol 22, No 1 (2017)
Original research articles
Published online: 2017-01-01
Submitted: 2015-06-27

Abstract

Aim

To investigate the dosimetric influence of filtered and flattening filter free (FFF) photon beam of 6 and 10[[ce:hsp sp="0.25"/]]MV energies on cervix RA radiotherapy planning and to find possibilities to develop the clinically acceptable RA plans with FFFB photon beam and explore their potential benefits to cervix cancer patients.

Background

FFF photon beams enhances the treatment delivery by increased dose rate which results in shorter treatment time, this shorter treatment time reduces intrafraction motion and enhance comfort to the patients.

Materials and methods

RA plans were generated for filtered and flattening filter free photon beams of 6 and 10[[ce:hsp sp="0.25"/]]MV energies using same dose–volumes constraints. RA plans were generated to deliver a dose of 50.4[[ce:hsp sp="0.25"/]]Gy in 28 fractions, for a cohort of eleven patients reported with cervix carcinoma. RA plans were evaluated in terms of PTV coverage, dose to OAR's, CI, HI, total no. of monitor units (MUs) and NTID and low dose volume of normal tissues.

Results

Clinically acceptable and similar plans were generated for filtered and flattening filter free photon beams. FFFB delivered slightly higher mean target dose (52.28[[ce:hsp sp="0.25"/]]Gy vs. 52.0[[ce:hsp sp="0.25"/]]Gy, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.000 for 6[[ce:hsp sp="0.25"/]]MV and 52.42[[ce:hsp sp="0.25"/]]Gy vs. 52.0[[ce:hsp sp="0.25"/]]Gy, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.000 for 10[[ce:hsp sp="0.25"/]]MV) less homogeneous (1.062 vs. 1.052, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.000 for 6[[ce:hsp sp="0.25"/]]MV and 1.066 vs. 1.051, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.000 for 10[[ce:hsp sp="0.25"/]]MV) and less conformal (1.007 vs. 1.004, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.104 for 6[[ce:hsp sp="0.25"/]]MV and 1.012 vs. 1.003, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.010 for 10[[ce:hsp sp="0.25"/]]MV) RA plans compared to FB. FFFB delivered more doses to the bladder and rectum, also required more numbers of MUs in comparison to FB.

Conclusions

This study concludes that FB is more beneficial for cervix RA planning in comparison to FFFB, as FB generates more conformal and homogenous rapid arc plans and offers better OAR's sparing.

Abstract

Aim

To investigate the dosimetric influence of filtered and flattening filter free (FFF) photon beam of 6 and 10[[ce:hsp sp="0.25"/]]MV energies on cervix RA radiotherapy planning and to find possibilities to develop the clinically acceptable RA plans with FFFB photon beam and explore their potential benefits to cervix cancer patients.

Background

FFF photon beams enhances the treatment delivery by increased dose rate which results in shorter treatment time, this shorter treatment time reduces intrafraction motion and enhance comfort to the patients.

Materials and methods

RA plans were generated for filtered and flattening filter free photon beams of 6 and 10[[ce:hsp sp="0.25"/]]MV energies using same dose–volumes constraints. RA plans were generated to deliver a dose of 50.4[[ce:hsp sp="0.25"/]]Gy in 28 fractions, for a cohort of eleven patients reported with cervix carcinoma. RA plans were evaluated in terms of PTV coverage, dose to OAR's, CI, HI, total no. of monitor units (MUs) and NTID and low dose volume of normal tissues.

Results

Clinically acceptable and similar plans were generated for filtered and flattening filter free photon beams. FFFB delivered slightly higher mean target dose (52.28[[ce:hsp sp="0.25"/]]Gy vs. 52.0[[ce:hsp sp="0.25"/]]Gy, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.000 for 6[[ce:hsp sp="0.25"/]]MV and 52.42[[ce:hsp sp="0.25"/]]Gy vs. 52.0[[ce:hsp sp="0.25"/]]Gy, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.000 for 10[[ce:hsp sp="0.25"/]]MV) less homogeneous (1.062 vs. 1.052, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.000 for 6[[ce:hsp sp="0.25"/]]MV and 1.066 vs. 1.051, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.000 for 10[[ce:hsp sp="0.25"/]]MV) and less conformal (1.007 vs. 1.004, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.104 for 6[[ce:hsp sp="0.25"/]]MV and 1.012 vs. 1.003, p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.010 for 10[[ce:hsp sp="0.25"/]]MV) RA plans compared to FB. FFFB delivered more doses to the bladder and rectum, also required more numbers of MUs in comparison to FB.

Conclusions

This study concludes that FB is more beneficial for cervix RA planning in comparison to FFFB, as FB generates more conformal and homogenous rapid arc plans and offers better OAR's sparing.

Get Citation

Keywords

Rapid arc plans; Filtered beam; Flattening filter free beam; Cervix carcinoma

About this article
Title

Dosimetric influence of filtered and flattening filter free photon beam on rapid arc (RA) radiotherapy planning in case of cervix carcinoma

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 22, No 1 (2017)

Pages

10-18

Published online

2017-01-01

DOI

10.1016/j.rpor.2016.09.010

Bibliographic record

Rep Pract Oncol Radiother 2017;22(1):10-18.

Keywords

Rapid arc plans
Filtered beam
Flattening filter free beam
Cervix carcinoma

Authors

Lalit Kumar
Girigesh Yadav
Kothanda Raman Samuvel
Manindra Bhushan
Pawan Kumar
Mahammood Suhail
Manoj Pal

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl